Record overview
Status and phase
Status: UNKNOWN
Phase: PHASE1, PHASE2
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Condition: KRAS G12C Mutant Advanced Solid Tumors
NCT06237400
A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Unknown Status Signal
Timeline signals: stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.